A first step to assess harm and benefit in clinical trials in one scale.

@article{Boers2010AFS,
  title={A first step to assess harm and benefit in clinical trials in one scale.},
  author={Maarten Boers and Peter M Brooks and James F. Fries and L. Sobita Simon and Vibeke Strand and Peter S L Tugwell},
  journal={Journal of clinical epidemiology},
  year={2010},
  volume={63 6},
  pages={627-32}
}
OBJECTIVE To develop a simple system to assess benefit and harm of treatment on a single scale. Harm and benefit signals from trials need to be placed in the proper perspective to decide on the value of a treatment. Several systems have been developed for assessment, but few attempt to incorporate both benefit and risk in the same metric while retaining enough simplicity to aid patients and clinicians in their decision making. STUDY DESIGN AND SETTING We designed a very simple 3 x 3 table… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
8 Citations
19 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Retracted: a quantitative approach to benefit-risk assessment of medicinesdpart 2; the practical application of a new model

  • RD Mann
  • Pharmacoepidemiol Drug Saf 2007;16:1180
  • 2007
1 Excerpt

Clinical epidemiology: how to do clinical practice research

  • RB Haynes, DL Sackett, GH Guyatt, P. Tugwell
  • 2006

Similar Papers

Loading similar papers…